This work is licensed under a Creative Commons Attribution 4.0 International License.
General Information
DRACP ID DRACP01997
Peptide Name
Sequence RIWGKHSRYIKIVKRLIQ
Sequence Length 18
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | EC50=50±10 µM | Not available | Not available | 1 |
Hemolytic Activity Human erythrocytes: Not active up to 400 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C107H180N34O22
Absent amino acids ACDEFMNPT
Common amino acids I
Mass 259823
Pl 12.27
Basic residues 7
Acidic residues 0
Hydrophobic residues 7
Net charge 7
Boman Index -4324
Hydrophobicity -51.67
Aliphatic Index 124.44
Half Life
Mammalian: 4.4 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 6990
Absorbance 280nm 411.18
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 29679519
Title Designing Anticancer Peptides by Constructive Machine Learning
Year 2018
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_14299
This work is licensed under a Creative Commons Attribution 4.0 International License.